|
This report is submitted beyond the 30-day timeframe due to delayed complaint entry.This issue has been identified and is being addressed under an active capa.The affected products with field complaints alleging pe-pur foam degradation have undergone the establishment of complaint codes specifically identifying foam degradation, for the dorma device.A field correction action (2021-06-a) was initiated, and medical device recall letters were issued.A field action was initiated to replace pe-pur foam in affected products; degradation was added to the respective dfmeas and the risk management file¿ er 2214809 v18(torch risk matrix) was updated to include hazards associated with foam degradation based on complaints analyzed through various health hazard evaluations (hhes).Risk tags ¿ degradation02, toxic01 reflect the safety risk assessment of design containing the affected pe-pur foam.These complaints were monitored and trended in accordance with the complaint trending procedures.If the complaints were determined to meet the criteria for escalation, they were escalated for risk assessment through the post market clinical escalation process.As of the date of submission for this report, there is no indication that complaints for the failure in question have led to unacceptable levels of severity or probabilities of harm, and therefore no further action will be pursued.The device mentioned in this complaint has exceeded its useful life per the applicable ifu.
|
|
A dorma 500 auto was returned to a third-party service center for service as part of the sound abatement foam recall process.During the evaluation of the device, the service technician observed visible foam particles was noted.Additionally, the device was scrapped by the service center after the evaluation was completed.
|